Next Article in Journal
Molecular Pattern and Density of Axons in the Long Head of the Biceps Tendon and the Superior Labrum
Previous Article in Journal
Approximate Mortality Risks between Hyperuricemia and Diabetes in the United States
Open AccessArticle

Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism

1
International Scientific Institute “Paul VI”, 100168 Rome, Italy
2
Divisione di Endocrinologia, Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, 00168 Rome, Italy
3
Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, 100168 Rome, Italy
4
Dipartimento di Scienze di laboratorio e infettivologiche, Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, 00168 Rome, Italy
5
Molecular Biology of Reproduction and Development Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain
6
Biochemistry and Molecular Genetics Service, Hospital Clínic, 08036 Barcelona, Spain
7
Laboratorio di Proteomica e Metabolomica, IRCCS Fondazione Santa Lucia, 100168 Rome, Italy
*
Author to whom correspondence should be addressed.
These Authors share senior authorship.
J. Clin. Med. 2019, 8(12), 2128; https://doi.org/10.3390/jcm8122128
Received: 11 October 2019 / Revised: 4 November 2019 / Accepted: 12 November 2019 / Published: 3 December 2019
(This article belongs to the Section Endocrinology & Metabolism)
In the grey zone of testosterone levels between 8 and 12 nmol/L, the usefulness of therapy is controversial; as such, markers of tissue action of androgens may be helpful in adjusting clinical decisions. To better understand the effect of the hypothalamic-pituitary-testicular axis on male accessory secretion, we performed a proteomic quantitative analysis of seminal plasma in patients with secondary hypogonadism, before and after testosterone replacement therapy (TRT). Ten male patients with postsurgical hypogonadotrophic hypogonadism were enrolled in this study, and five of these patients were evaluated after testosterone treatment. Ten men with proven fertility were selected as a control group. An aliquot of seminal plasma from each individual was subjected to an in-solution digestion protocol and analyzed using an Ultimate 3000 RSLC-nano HPLC apparatus coupled to a LTQ Orbitrap Elite mass spectrometer. The label-free quantitative analysis was performed via Precursor Ions Area Detector Node. Eleven proteins were identified as decreased in hypogonadic patients versus controls, which are primarily included in hydrolase activity and protein binding activity. The comparison of the proteome before and after TRT comes about within the discovery of six increased proteins. This is the primary application of quantitative proteomics pointed to uncover a cluster of proteins reflecting an impairment not only of spermatogenesis but of the epididymal and prostate epithelial cell secretory function in male hypogonadism. The identified proteins might represent putative clinical markers valuable within the follow-up of patients with distinctive grades of male hypogonadism. View Full-Text
Keywords: seminal plasma; proteomics; testosterone; testosterone deficiency; hypogonadism; accessory glands seminal plasma; proteomics; testosterone; testosterone deficiency; hypogonadism; accessory glands
Show Figures

Figure 1

MDPI and ACS Style

Grande, G.; Vincenzoni, F.; Mancini, F.; Barrachina, F.; Giampietro, A.; Castagnola, M.; Urbani, A.; Oliva, R.; Milardi, D.; Pontecorvi, A. Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism. J. Clin. Med. 2019, 8, 2128.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop